Gene · 38
NIH grants1,504
NIH grants whose papers are about the gene, through NIH's grant-paper links.
121 to 140 of 1,504
Download this page as JSON| Grant | Title | ACAT1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI118932 | Type IV Protein Secretion in Helicobacter pylori | 1 | 2025 |
| R01AI158154 | Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection | 1 | 2025 |
| R01AI158357 | Oxysterol Regulation of Microbial Pathogenesis | 1 | 2025 |
| R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 1 | 2025 |
| R01CA051497 | Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis | 1 | 2025 |
| R01CA062130 | Role of heat shock transcription factor HSF1 in tumorigenesis | 1 | 2025 |
| R01CA090764 | PI3K/PTEN/Akt signaling and the genesis of cancer | 1 | 2025 |
| R01CA143130 | Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal | 1 | 2025 |
| R01CA157429 | Overcoming Drug Resistance of Castration-Resistant Prostate Cancer | 1 | 2025 |
| R01CA167413 | Advancing molecular fluorescence-guided surgery platform | 1 | 2025 |
| R01CA207513 | Role of KLHL6 inactivation in mature B-cell malignancies | 1 | 2025 |
| R01CA252092 | Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer | 1 | 2025 |
| R01CA257258 | Small molecule probes of MYC stability and function intumorigenesis | 1 | 2025 |
| R01CA260857 | Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy | 1 | 2025 |
| R01CA260872 | A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients | 1 | 2025 |
| R01CA276933 | Role of heat shock transcription factors (HSFs) in hematological malignancies | 1 | 2025 |
| R01DK030292 | Genomic and metabolomic foundations of human-microbial symbiosis in the gut | 1 | 2025 |
| R01DK038389 | Lipid transport in the intestine | 1 | 2025 |
| R01DK052230 | Regulation of Intestinal Epithelial Cell Proliferation | 1 | 2025 |
| R01DK062370 | Identifying Genes for Type 2 Diabetes: FUSION | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/grants?page=7